Ece Özyağcı

Ece Özyağcı

Auto-generated profile, based on publicly available information

Ece Özyağcı


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
EOEbru Toksoy Oner
Ebru Toksoy Oner
EÖEce Özyağcı
Ece Özyağcı
STSelay TORNACI
Selay TORNACI
DGDana Galkina
Dana Galkina
EKElina Kelle
Elina Kelle
GSGirts Salms
Girts Salms
Hydrogels are widely investigated as tissue engineering scaffolds due to their structural similarity to the extracellular matrix and their ability to support cell growth and controlled drug delivery. In this study, levan-based microgels were developed as injectable scaffolds capable of filling amorphous and hard-to-reach soft tissue defects while enabling controlled release of cannabidiol (CBD). A cytocompatible and immuno-neutral levan hydrogel with a porous architecture and high water uptake was successfully synthesized. The physicochemical, rheological, and biological properties of the hydrogel were systematically evaluated in different physical forms (oven-dried, lyophilized, bulk, ground, and injectable) using swelling analysis, scanning electron microscopy (SEM), frequency and amplitude sweep rheological tests, CCK-8 cytotoxicity assays, ELISA, and in vitro drug release studies. The hydrogel exhibited a high swelling capacity (approximately 15–18 g/g) and a well-developed porous structure throughout both surface and cross-sectional regions. Cytocompatibility was confirmed with adipocytes, gingival mesenchymal stem cells (GMSC), human osteoblasts (HOB), and human fibroblasts (PCS-201-012). ELISA results demonstrated stable interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) secretion levels in GMSC cultures, indicating an immuno-neutral response. Furthermore, the hydrogel enabled a low and sustained release of CBD. Collectively, these findings highlight the potential of levan-based hydrogels as injectable, wound healing–oriented drug delivery systems for soft tissue engineering applications.

22 October 2026 in Macromolecular Materials and Engineering
Verified
Journal Article
Open access
PDF file
EÖEce Özyağcı
Ece Özyağcı
STSelay TORNACI
Selay TORNACI
DGDana Galkina
Dana Galkina
EKElina Kelle
Elina Kelle
GSGirts Salms
Girts Salms
EÖEbru Toksoy Öner
Ebru Toksoy Öner
Hydrogels are widely investigated as tissue engineering scaffolds due to their structural similarity to the extracellular matrix and their ability to support cell growth and controlled drug delivery. In this study, levan‐based microgels were developed as injectable scaffolds capable of filling amorphous and hard‐to‐reach soft tissue defects while enabling controlled release of cannabidiol (CBD). A cytocompatible and immuno‐neutral levan hydrogel with a porous architecture and high water uptake was successfully synthesized. The physicochemical, rheological, and biological properties of the hydrogel were systematically evaluated in different physical forms (oven‐dried, lyophilized, bulk, ground, and injectable). The hydrogel exhibited a high swelling capacity (approximately 15–18 g g −1 ) and a well‐developed porous structure throughout both surface and cross‐sectional regions. Cytocompatibility was confirmed with adipocytes, gingival mesenchymal stem cells (GMSC), human osteoblasts (HOB), and human fibroblasts (PCS‐201‐012). ELISA results demonstrated stable interleukin‐6 (IL‐6) and tumor necrosis factor‐α (TNF‐α) secretion levels in GMSC cultures, indicating an immuno‐neutral response. Furthermore, the hydrogel enabled a low and sustained release of CBD. Collectively, these findings highlight the potential of levan‐based hydrogels as injectable, wound‐healing‐oriented drug delivery systems for soft tissue engineering applications.